What the Latuda TV commercial - Struggling is about.
Latuda is a medication that is used to treat bipolar depression in adults as well as schizophrenia in adults and adolescents. The TV spot titled "Struggling" advertises this medication as a solution for those struggling with these conditions.
The commercial opens with a shot of a woman sitting on the edge of a bed, looking down at her hands. She appears to be withdrawn and sad. The voice-over begins, saying, "Living with bipolar depression or schizophrenia can make everyday activities feel tough. If you're struggling with your symptoms, Latuda can help."
The ad then shows the same woman engaging in various activities, like talking with friends, cooking, and playing board games. Throughout each activity, she seems more present, energized, and connected with the world around her. The voice-over continues, "Latuda is proven to significantly reduce bipolar depression and schizophrenia symptoms when taken as directed."
The commercial ends with the woman sitting back on the edge of the bed, but she appears to be more content and relaxed than she was at the beginning of the ad. The voice-over closes with, "Don't give up hope. Talk to your doctor about switching to Latuda today."
Overall, the Latuda TV Spot presents the medication as a solution for those struggling with bipolar depression and schizophrenia. It highlights how the medication can make everyday activities feel more manageable and enjoyable while reducing symptoms. The ad aims to encourage individuals to seek help and not give up hope by talking to their doctors about Latuda.
Latuda TV commercial - Struggling produced for
Latuda
was first shown on television on April 12, 2015.
Frequently Asked Questions about latuda tv spot, 'struggling'
Lurasidone Tablets. Latuda® is a brand of lurasidone that comes in a tablet form. It's a type of antiphychotic that can treat mental health conditions like schizophrenia or bipolar disorder. You should take this medication at regular intervals and with food.
Latuda (generic name: lurasidone) is an atypical antipsychotic approved for the treatment of patients with schizophrenia and bipolar depression. Latuda may be used as monotherapy (as a single drug) or in combination with the mood stabilizers lithium or valproate in the treatment of bipolar depression.
LATUDA is the first FDA-approved medication for bipolar depression that can either be taken on its own by children (10 to 17 years) and adults or as part of a treatment plan along with a mood-stabilizer, either lithium or valproate, by adults.
Generic Latuda (Lurasidone Hydrochloride) Is Now Available.
In some cases, antipsychotic drugs such as Latuda can increase the risk of death when used in older adults who have psychosis related to dementia. Suicidal thoughts and behaviors.
Latuda can sometimes cause harmful effects in people who have certain conditions. This is known as a drug-condition interaction. Other factors may also affect whether Latuda is a good treatment option for you. Talk with your doctor about your health history before you take Latuda.
Latuda has a boxed warning for the risk of suicidal thoughts and behaviors in children. A boxed warning is the most serious warning from the FDA.
Lurasidone acts mainly by blocking the receptors for the neurotransmitters dopamine, 5- hydroxytryptamine (also called serotonin) and noradrenaline. Since these neurotransmitters play a role in schizophrenia, by blocking their receptors lurasidone helps to normalise the activity of the brain, reducing symptoms.
Lurasidone acts mainly by blocking the receptors for the neurotransmitters dopamine, 5- hydroxytryptamine (also called serotonin) and noradrenaline. Since these neurotransmitters play a role in schizophrenia, by blocking their receptors lurasidone helps to normalise the activity of the brain, reducing symptoms.
The effectiveness of Latuda for longer than 6 weeks has not been evaluated in controlled clinical studies. However, your doctor will periodically reevaluate your response to the long-term use of Latuda if you remain on treatment for longer than 6 weeks.
Latuda has an average rating of 6.2 out of 10 from a total of 785 reviews on Drugs.com. 51% of reviewers reported a positive experience, while 30% reported a negative experience.
It has been postulated that the lurasidone may be beneficial for treating the cognitive and memory deficiencies in schizophrenia based on several factors: (1) lurasidone does not possess any activity against muscarinic acetylcholine or histamine H1 receptors, two receptors that potentially disrupt memory and learning; ...